Should I Buy ENTX? ENTX 2026 Analysis

Should You Buy Entera Bio Ltd (ENTX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

1.040

1 Day change

-11.11%

52 Week Range

3.220

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient investor: price is in a clear bearish trend (SMA_200 > SMA_20 > SMA_5) and momentum is still deteriorating (MACD histogram negative and expanding).
RSI(6) at ~10.9 signals extreme oversold conditions, but oversold can persist in micro-cap downtrends; without a catalyst or confirmed reversal, the risk of another leg down remains high.
Intellectia signals are absent today (no AI Stock Picker, no SwingMax), so there is no strong proprietary edge to justify an immediate entry.
Best stance from the provided data: wait/avoid new longs until price reclaims key levels (at least S1/pivot) and momentum stabilizes.

Technical Analysis

Trend: Bearish (SMA_200 > SMA_20 > SMA_5), indicating a sustained downtrend across long-, mid-, and short-term timeframes.
Momentum: MACD histogram -0.0203 below zero and negatively expanding → downside momentum is strengthening, not fading.
Mean-reversion setup: RSI_6 = 10.853 (deep oversold) → bounce is possible, but not confirmed; oversold alone is not a timing signal.
Levels: Pivot 1.399 (major overhead), S1 1.204 (near current price 1.18), S2 1.084 (next downside area). Resistance: R1 1.594, R2 1.714.
Probabilistic pattern read: Similar-pattern model implies ~70% chance of -0.36% next day, with modest upside bias over 1 week (+1.64%) and 1 month (+3.7%), but that upside is small relative to ongoing technical weakness and gap-down risk.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Open interest: Calls 376 vs Puts 1 → put/call OI ratio effectively 0, but this is likely driven by very low liquidity rather than strong bullish conviction.
Options volume: 0 today (and very low recent averages) → options market is not providing reliable sentiment.
Volatility: 30D IV ~763% with IV percentile ~78.9 / IV rank ~74 → extremely elevated implied volatility, consistent with speculative/high-risk pricing and potential for sharp moves; not supportive of a clean, low-risk long entry.

Technical Summary

Sell

Buy

Positive Catalysts

- Technical mean-reversion potential: extremely oversold RSI can trigger sharp short-term bounces if selling pressure eases.
- No significant insider or hedge fund selling trends reported recently (both neutral), reducing the risk of an obvious supply overhang from those groups.
- Pattern-based forecast suggests modest positive drift over the next week/month if the stock can stabilize above nearby support.

Neutral/Negative Catalysts

- Strong downtrend and worsening momentum (bearish moving averages + MACD expanding negative) increases probability that “oversold” becomes “more oversold.”
- No news in the past week: absence of fresh catalysts makes a durable reversal less likely in the near term.
- Extremely high implied volatility with near-zero options volume/liquidity suggests unstable pricing and limited ability to read sentiment.
- Price is below/near S1 (1.204); a clean break can open room toward S2 (1.084).

Financial Performance

Latest reported quarter: 2025/Q3.
Revenue: 0, down -100% YoY → indicates no operating revenue contribution in the quarter.
Net income: -$3.2M, improved ~5.93% YoY (still meaningfully loss-making).
EPS: -0.07, down -12.5% YoY → per-share losses worsened despite slight net loss improvement (likely share count/other effects).
Overall: Financials show continued development-stage characteristics (no revenue, ongoing losses), which typically increases reliance on catalysts and/or funding conditions.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so a Wall Street consensus trend cannot be confirmed from this dataset.
Practical pro/con view based on available info: Pros = potential oversold bounce; Cons = no signals/catalysts, ongoing losses with zero revenue, and a firmly bearish technical structure.
Politicians/other influential trading: No recent congress trading data available (no actionable signal from political activity).

1 Analyst Rating

Wall Street analysts forecast ENTX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENTX is 10 USD with a low forecast of 10 USD and a high forecast of 10 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 1.170

Low

Averages

High

Current: 1.170

Low

Averages

High

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Reiterates

$10

AI Analysis

2025-03-18

Reason